海外招聘者

2022年4月28日時点
アルファベット順・敬称略

	Jun-ichi Abe (University of Texas MD Anderson Cancer Center, USA) Speaker Symposium 4 Cardio-oncology: Where do we come from? What are we? Where are we going?
	Ash A. Alizadeh (Moghadam Family Professor of Medicine Divisions of Oncology & Hematology Stanford Cancer Institute, USA) Speaker Special Symposium Molecular Profiling of Lymphomas Using Circulating Tumor DNA
	Antonio Almeida (Hospital da Luz Lisboa Católica Medical School, Portugal) Chair JSH-EHA Joint Symposium Recent advances in the management of lymphoid malignancies Speaker EHA Special Lecture Challenges in the Diagnosis and Treatment of Chronic Myelomonocytic Leukemia
	Suning Chen (Jiangsu Institute of Hematology. The First afffiliated hospital of Soochow Unviersity, China) Speaker Asian Joint Panel Discussion Current status of acute promyelocytic leukemia in China.
	Jean Marie Connors (Harvard Medical School Brigham and Women's Hospital Dana-Farber Cancer Institute, USA) Speaker Symposium 4 COVID Associated Thrombosis—What We Know in 2022 commentator SETP (Scientific Exchange Training Program) Hemostasis/Thrombosis and COVID-19
	Yelena Ginzburg (Icahn School of Medicine at Mount Sinai, USA) Speaker Symposium 2 Novel mechanisms of ineffective erythropoiesis in β-thalassemia
	Hsin-An Hou (Internal Medicine (Division of Hematology) , National Taiwan University Hospital, Taiwan) Speaker Asian Joint Panel Discussion Current status, challenges and clinical relevance of targeted therapy in Taiwan AML patients
	Martin Hutchings (Department of Haematology, Rigshospitalet and University of Copenhagen, Denmark) Speaker JSH-EHA Joint Symposium CD3XCD20 bispecific antidodies for B-cell lymphoma
	James Kochenderfer (National Cancer Institute, National Institutes of Health, USA) Speaker JSH-ASH Joint Symposium Anti-BCMA CAR T-cell therapy for multiple myeloma
	Diane Krause (Yale University, USA) Speaker Symposium 2 Regulation of Megakaryocytic-Erythroid Progenitor Fate Specification
	Dan Landau (WCM/NYGC, USA) Speaker Symposium 1 Somatic evolutionin normal and neoplastic hematopoiesis through the lens of single-cell multi-omics
	Vikram Mathews (Dept of Haematology, Christian Medical College, India) Speaker Asian Joint Panel Discussion Promise and challenges with targeted therapy in AML: a perspective from India
	Adam J Mead (University of Oxford, UK) Speaker Symposium 1 Genetic and Non-Genetic Determinants of Disease Progression in Myeloproliferative Neoplasms
	Alberto Orfao (University of Salamanca, Spain) Speaker Symposium 6 Detection of minimal residual disease in multiple myeloma: application for clinical care
	Marco Ruella (Center for Cellular Immunotherapy, University of Pennsylvania, USA) Speaker JSH-ASH Joint Symposium CD5 knock out enhances the anti-tumor activity of chimeric antigen receptor T cells
	David Sallman (Moffitt Cancer Center, USA) Speaker Symposium 5 Targeting CD47/SIRPα axis for the treatment of MDS/AML
	Dong Yeop Shin (Internal Medicine, Seoul National University Hospital, Korea) Speaker Asian Joint Panel Discussion Molecular targeting therapy for AML in Korea
	Liran Shlush (Weizmann institute of science, Israel) Speaker Symposium 1 Mutation mechanisms in clonal hematopoiesis
	Catherine Smith (University of California San Francisco, USA) Speaker Symposium 5 Resistance to FLT3 Inhibitors in AML
	Sampath Venkata Sreekanth (The Department of Haematology, Tan Tock Seng Hospital, Singapore) Chair Asian Joint Panel Discussion Recent progresses of molecular targeting therapy: how has it changed AML therapy in Asia? Speaker Asian Joint Panel Discussion How I Use Venetoclax in Acute Myeloid Leukemia
	Adisak Tantiworawit (Internal Medicine, ChiangMai University, Thailand) Speaker Asian Joint Panel Discussion Molecular target for FLT3-mutated AML: Data from Thai Acute Leukemia Working Group
	Hervé Tilly (Department of Hematology, Centre Henri-Becquerel, Rouen, France) Speaker JSH-EHA Joint Symposium Antibody drug conjugates in the treatment of B-cell lymphomas
	Jeffrey W. Tyner (Knight Cancer Institute, Oregon Health & Science University, USA) Speaker Symposium 5 Big Data for Novel Therapeutic Strategies in Myeloid Malignancies commentator SETP (Scientific Exchange Training Program) Acute Myeloid Leukemia
	Brian A Walker (Indiana University School of Medicine, USA) Speaker Symposium 6 Molecular biomarkers of MM in clinical practice –advances and perspectives commentator SETP (Scientific Exchange Training Program) Multiple MyelomaMultiple Myeloma
	Andrew Wei (Peter MacCallum Cancer Centre Walter and Eliza Hall Institute, Australia) Speaker Symposium 5 Venetoclax in AML: what we have learned
	Irving Weissman (Institute for Stem Cell Biology and Regenerative Medicine / Stanford Ludwig Center for Cancer Stem Cell Research and Medicine, USA) Speaker Special Lecture Normal and Neoplastic Stem Cells
	Jane N. Winter (Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, USA) Chair JSH-ASH Joint Symposium CAR-T Therapy from the Bench to the Clinic and Back Speaker ASH Special Lecture Diffuse Large B-cell Lymphoma: 2022 Update commentator SETP (Scientific Exchange Training Program) Malignant Lymphoma
	Jun J Yang (St. Jude Children’s Research Hospital, USA) Speaker Symposium 3 Pharmacogenomic Landscape of Acute Lymphoblastic Leukemia
	Jinghui Zhang (St Jude Children's Research Hospital, USA) Speaker Special Symposium Utility of Whole Genome Sequencing in Clinical Profiling of Pediatric Cancer